Q&A with Dr. Lydie Debaize: Targeting Drug-Resistant Blood Cancer Cells
Lydie Debaize, PhD, is a postdoctoral trainee at the Dana-Farber Cancer Institute and 2023 recipient of a PhRMA Foundation Postdoctoral Fellowship in Drug Discovery.
BlogLydie Debaize, PhD, is a postdoctoral trainee at the Dana-Farber Cancer Institute and 2023 recipient of a PhRMA Foundation Postdoctoral Fellowship in Drug Discovery.
BlogThe PhRMA Foundation awarded two $500,000 Frontier Awards for research applying patient-centered value assessment models to help guide health care decision-making.
Press ReleasesMeaningful patient engagement is critical to overcome the challenges in making value assessment more patient-centric.
BlogMade Harumi Padmaswari is pursuing her PhD at the University of Arkansas and researching therapeutic treatments for duchenne muscular dystrophy, a common genetic disease that mainly affects young boys.
Blog